GLP‐1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
D Ryan, A Acosta - Obesity, 2015 - Wiley Online Library
Obective Glucagon‐like peptide‐1 (GLP‐1) receptor agonists are indicated for treatment of
type 2 diabetes since they mimic the actions of native GLP‐1 on pancreatic islet cells …
type 2 diabetes since they mimic the actions of native GLP‐1 on pancreatic islet cells …
GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond.
D Ryan, A Acosta - Obesity (Silver Spring, Md.), 2015 - europepmc.org
Objective Glucagon-like peptide-1 (GLP-1) receptor agonists are indicated for treatment of
type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet cells …
type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet cells …
GLP-1 receptor agonists: nonglycemic clinical effects in weight loss and beyond.
D Ryan, A Acosta - 2015 - cabidigitallibrary.org
Abstract Objective: Glucagon-like peptide-1 (GLP-1) receptor agonists are indicated for
treatment of type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet …
treatment of type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet …
[PDF][PDF] GLP-1 Receptor Agonists: Nonglycemic Clinical Effects in Weight Loss and Beyond
D Ryan, A Acosta - cyberleninka.org
Results: GLP-1 receptors are distributed widely in a number of tissues in humans, and their
effects are not limited to the well-recognized effects on glycemia. Nonglycemic effects …
effects are not limited to the well-recognized effects on glycemia. Nonglycemic effects …
GLP-1 Receptor Agonists: Nonglycemic Clinical Effects in Weight Loss and Beyond
D Ryan, A Acosta - Obesity, 2015 - search.proquest.com
Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists are indicated for treatment of
type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet cells …
type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet cells …
GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
D Ryan, A Acosta - Obesity (Silver Spring, Md.), 2015 - pubmed.ncbi.nlm.nih.gov
Objective Glucagon-like peptide-1 (GLP-1) receptor agonists are indicated for treatment of
type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet cells …
type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet cells …
[HTML][HTML] GLP-1 Receptor Agonists: Nonglycemic Clinical Effects in Weight Loss and Beyond
D Ryan, A Acosta - Obesity (Silver Spring, Md.), 2015 - ncbi.nlm.nih.gov
Methods A literature search was conducted to identify preclinical and clinical evidence on
nonglycemic effects of GLP-1 receptor agonists. Results GLP-1 receptors are distributed …
nonglycemic effects of GLP-1 receptor agonists. Results GLP-1 receptors are distributed …
GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
D Ryan, A Acosta - Obesity, 2015 - mayoclinic.pure.elsevier.com
Abstract Obective Glucagon-like peptide-1 (GLP-1) receptor agonists are indicated for
treatment of type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet …
treatment of type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet …
GLP‐1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
D Ryan, A Acosta - Obesity, 2015 - infona.pl
Obective Glucagon‐like peptide‐1 (GLP‐1) receptor agonists are indicated for treatment of
type 2 diabetes since they mimic the actions of native GLP‐1 on pancreatic islet cells …
type 2 diabetes since they mimic the actions of native GLP‐1 on pancreatic islet cells …
GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
D Ryan, A Acosta - Obesity, 2015 - mayoclinic.elsevierpure.com
Abstract Obective Glucagon-like peptide-1 (GLP-1) receptor agonists are indicated for
treatment of type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet …
treatment of type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet …